158 related articles for article (PubMed ID: 32729777)
1. Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications.
Stadskleiv K; Stensvold E; Stokka K; Bechensteen AG; Brandal P
Clin Neuropsychol; 2022 Apr; 36(3):600-625. PubMed ID: 32729777
[No Abstract] [Full Text] [Related]
2. Neurocognitive Function and Health-Related Quality of Life in Pediatric Korean Survivors of Medulloblastoma.
Yoo HJ; Kim H; Park HJ; Kim DS; Ra YS; Shin HY
J Korean Med Sci; 2016 Nov; 31(11):1726-1734. PubMed ID: 27709849
[TBL] [Abstract][Full Text] [Related]
3. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.
Schreiber JE; Palmer SL; Conklin HM; Mabbott DJ; Swain MA; Bonner MJ; Chapieski ML; Huang L; Zhang H; Gajjar A
Neuro Oncol; 2017 Nov; 19(12):1673-1682. PubMed ID: 29016818
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma.
Maddrey AM; Bergeron JA; Lombardo ER; McDonald NK; Mulne AF; Barenberg PD; Bowers DC
J Neurooncol; 2005 May; 72(3):245-53. PubMed ID: 15937648
[TBL] [Abstract][Full Text] [Related]
5. Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.
Koral K; Roy D; Timmons CF; Gargan L; Bowers DC
Acad Radiol; 2012 Jan; 19(1):35-9. PubMed ID: 22054800
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neuropsychological functioning in pediatric posterior fossa tumor survivors: Medulloblastoma, low-grade astrocytoma, and healthy controls.
Levitch CF; Holland AA; Bledsoe J; Kim SY; Barnett M; Ramjan S; Sands SA
Pediatr Blood Cancer; 2022 Feb; 69(2):e29491. PubMed ID: 34842359
[TBL] [Abstract][Full Text] [Related]
7. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.
King AA; Seidel K; Di C; Leisenring WM; Perkins SM; Krull KR; Sklar CA; Green DM; Armstrong GT; Zeltzer LK; Wells E; Stovall M; Ullrich NJ; Oeffinger KC; Robison LL; Packer RJ
Neuro Oncol; 2017 May; 19(5):689-698. PubMed ID: 28039368
[TBL] [Abstract][Full Text] [Related]
8. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.
Rønning C; Sundet K; Due-Tønnessen B; Lundar T; Helseth E
Pediatr Neurosurg; 2005; 41(1):15-21. PubMed ID: 15886508
[TBL] [Abstract][Full Text] [Related]
9. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
10. Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors.
Stensvold E; Stadskleiv K; Myklebust TÅ; Wesenberg F; Helseth E; Bechensteen AG; Brandal P
Acta Paediatr; 2020 Sep; 109(9):1875-1886. PubMed ID: 31977119
[TBL] [Abstract][Full Text] [Related]
11. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
[TBL] [Abstract][Full Text] [Related]
12. Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma.
Hardy KK; Bonner MJ; Willard VW; Watral MA; Gururangan S
Psychooncology; 2008 Nov; 17(11):1157-61. PubMed ID: 18636431
[TBL] [Abstract][Full Text] [Related]
13. Cerebral white matter fractional anisotropy and tract volume as measured by MR imaging are associated with impaired cognitive and motor function in pediatric posterior fossa tumor survivors.
Rueckriegel SM; Bruhn H; Thomale UW; Hernáiz Driever P
Pediatr Blood Cancer; 2015 Jul; 62(7):1252-8. PubMed ID: 25850573
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of neuropsychological outcomes following posterior fossa tumor surgery in children.
Hanzlik E; Woodrome SE; Abdel-Baki M; Geller TJ; Elbabaa SK
Childs Nerv Syst; 2015 Oct; 31(10):1869-75. PubMed ID: 26351236
[TBL] [Abstract][Full Text] [Related]
15. Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma.
Brinkman TM; Reddick WE; Luxton J; Glass JO; Sabin ND; Srivastava DK; Robison LL; Hudson MM; Krull KR
Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv25-36. PubMed ID: 23095827
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood.
Trojanowski JQ; Fung KM; Rorke LB; Tohyama T; Yachnis AT; Lee VM
Mol Chem Neuropathol; 1994; 21(2-3):219-39. PubMed ID: 8086035
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor.
Harris RD; Richard MA; Gramatges MMJ; Wilhelm K; Scheurer ME; Lupo PJ; Brown AL
Pediatr Hematol Oncol; 2023 May; 40(4):407-411. PubMed ID: 35862575
[TBL] [Abstract][Full Text] [Related]
18. Possible association between the integrity of cerebellar pathways and neurocognitive performance in children with posterior fossa tumors.
Liguoro I; Passone E; Zilli T; Maieron M; De Colle MC; Skrap M; Dolcemascolo V; Sommariva G; Cogo P; Tomasino B
Pediatr Blood Cancer; 2020 Sep; 67(9):e28538. PubMed ID: 32652734
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological sequelae of the treatment of children with medulloblastoma.
Dennis M; Spiegler BJ; Hetherington CR; Greenberg ML
J Neurooncol; 1996 Jul; 29(1):91-101. PubMed ID: 8817420
[TBL] [Abstract][Full Text] [Related]
20. Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes.
Edelstein K; Spiegler BJ; Fung S; Panzarella T; Mabbott DJ; Jewitt N; D'Agostino NM; Mason WP; Bouffet E; Tabori U; Laperriere N; Hodgson DC
Neuro Oncol; 2011 May; 13(5):536-45. PubMed ID: 21367970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
